Mylan Claims Fall In IP Suit Over Generic Azilect
Judge Jose L. Linares of the U.S. District Court for the District of New Jersey granted Teva's motion to dismiss Mylan's counterclaims and affirmative defense alleging that U.S. Patent Number 5,453,446 was unenforceable due to the plaintiff intentionally misleading the examiner during the prosecution of the asserted patent...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login